Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA

Carlos T Moraes, Federica Ciacci, Gabriella Silvestri, Sara Shanske, Monica Sciacco, Michio Hirano, Eric A. Schon, Eduardo Bonilla, Salvatore DiMauro

Research output: Contribution to journalArticle

201 Citations (Scopus)

Abstract

Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is commonly associated with an A → G transition at position 3243 of the mitochondrial DNA. To determine the diversity of clinical syndromes associated with this mutation, 91 patients with mitochondrial encephalomyopathies that did not conform to the MELAS phenotype were screened. Twenty one patients with the 3243 mutation, most of whom had progressive external ophthalmoplegia (PEO) were found. Clinical features did not distinguish PEO patients with the 3243 mutation from those with large-scale deletions of mtDNA. However, most cases with single large-scale mtDNA deletions were sporadic, whereas most patients with the 3243 mutation had affected maternal relatives. Histochemical studies of muscle showed that cytochrome c oxidase (COX) deficiency was more severe in patients with PEO than in patients with typical MELAS, even though PEO patients had a lower percentage of mutant genomes in muscle. These data imply that the 3243 mutation is a major cause of familial PEO, and suggests that the threshold number of mtDNAs harboring the 3243 mutation necessary to affect a particular tissue vary in different patients. The proportion of mutant genomes in combination with other, still undefined, tissue-specific modulating factors seem to determine the overall clinical syndrome.

Original languageEnglish
Pages (from-to)43-50
Number of pages8
JournalNeuromuscular Disorders
Volume3
Issue number1
DOIs
StatePublished - Jan 1 1993
Externally publishedYes

Fingerprint

Lactic Acidosis
Mitochondrial DNA
Chronic Progressive External Ophthalmoplegia
Stroke
Mutation
Cytochrome-c Oxidase Deficiency
Mitochondrial Encephalomyopathies
Genome
Muscles
Mitochondrial encephalopathy
Mothers
Phenotype

Keywords

  • MELAS
  • mtDNA
  • PEO

ASJC Scopus subject areas

  • Clinical Neurology
  • Pediatrics, Perinatology, and Child Health
  • Developmental Neuroscience
  • Neurology

Cite this

Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. / Moraes, Carlos T; Ciacci, Federica; Silvestri, Gabriella; Shanske, Sara; Sciacco, Monica; Hirano, Michio; Schon, Eric A.; Bonilla, Eduardo; DiMauro, Salvatore.

In: Neuromuscular Disorders, Vol. 3, No. 1, 01.01.1993, p. 43-50.

Research output: Contribution to journalArticle

Moraes, CT, Ciacci, F, Silvestri, G, Shanske, S, Sciacco, M, Hirano, M, Schon, EA, Bonilla, E & DiMauro, S 1993, 'Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA', Neuromuscular Disorders, vol. 3, no. 1, pp. 43-50. https://doi.org/10.1016/0960-8966(93)90040-Q
Moraes, Carlos T ; Ciacci, Federica ; Silvestri, Gabriella ; Shanske, Sara ; Sciacco, Monica ; Hirano, Michio ; Schon, Eric A. ; Bonilla, Eduardo ; DiMauro, Salvatore. / Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA. In: Neuromuscular Disorders. 1993 ; Vol. 3, No. 1. pp. 43-50.
@article{67d8c60c41e342fca1175d05b2f8c515,
title = "Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA",
abstract = "Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is commonly associated with an A → G transition at position 3243 of the mitochondrial DNA. To determine the diversity of clinical syndromes associated with this mutation, 91 patients with mitochondrial encephalomyopathies that did not conform to the MELAS phenotype were screened. Twenty one patients with the 3243 mutation, most of whom had progressive external ophthalmoplegia (PEO) were found. Clinical features did not distinguish PEO patients with the 3243 mutation from those with large-scale deletions of mtDNA. However, most cases with single large-scale mtDNA deletions were sporadic, whereas most patients with the 3243 mutation had affected maternal relatives. Histochemical studies of muscle showed that cytochrome c oxidase (COX) deficiency was more severe in patients with PEO than in patients with typical MELAS, even though PEO patients had a lower percentage of mutant genomes in muscle. These data imply that the 3243 mutation is a major cause of familial PEO, and suggests that the threshold number of mtDNAs harboring the 3243 mutation necessary to affect a particular tissue vary in different patients. The proportion of mutant genomes in combination with other, still undefined, tissue-specific modulating factors seem to determine the overall clinical syndrome.",
keywords = "MELAS, mtDNA, PEO",
author = "Moraes, {Carlos T} and Federica Ciacci and Gabriella Silvestri and Sara Shanske and Monica Sciacco and Michio Hirano and Schon, {Eric A.} and Eduardo Bonilla and Salvatore DiMauro",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/0960-8966(93)90040-Q",
language = "English",
volume = "3",
pages = "43--50",
journal = "Neuromuscular Disorders",
issn = "0960-8966",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Atypical clinical presentations associated with the MELAS mutation at position 3243 of human mitochondrial DNA

AU - Moraes, Carlos T

AU - Ciacci, Federica

AU - Silvestri, Gabriella

AU - Shanske, Sara

AU - Sciacco, Monica

AU - Hirano, Michio

AU - Schon, Eric A.

AU - Bonilla, Eduardo

AU - DiMauro, Salvatore

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is commonly associated with an A → G transition at position 3243 of the mitochondrial DNA. To determine the diversity of clinical syndromes associated with this mutation, 91 patients with mitochondrial encephalomyopathies that did not conform to the MELAS phenotype were screened. Twenty one patients with the 3243 mutation, most of whom had progressive external ophthalmoplegia (PEO) were found. Clinical features did not distinguish PEO patients with the 3243 mutation from those with large-scale deletions of mtDNA. However, most cases with single large-scale mtDNA deletions were sporadic, whereas most patients with the 3243 mutation had affected maternal relatives. Histochemical studies of muscle showed that cytochrome c oxidase (COX) deficiency was more severe in patients with PEO than in patients with typical MELAS, even though PEO patients had a lower percentage of mutant genomes in muscle. These data imply that the 3243 mutation is a major cause of familial PEO, and suggests that the threshold number of mtDNAs harboring the 3243 mutation necessary to affect a particular tissue vary in different patients. The proportion of mutant genomes in combination with other, still undefined, tissue-specific modulating factors seem to determine the overall clinical syndrome.

AB - Mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) is commonly associated with an A → G transition at position 3243 of the mitochondrial DNA. To determine the diversity of clinical syndromes associated with this mutation, 91 patients with mitochondrial encephalomyopathies that did not conform to the MELAS phenotype were screened. Twenty one patients with the 3243 mutation, most of whom had progressive external ophthalmoplegia (PEO) were found. Clinical features did not distinguish PEO patients with the 3243 mutation from those with large-scale deletions of mtDNA. However, most cases with single large-scale mtDNA deletions were sporadic, whereas most patients with the 3243 mutation had affected maternal relatives. Histochemical studies of muscle showed that cytochrome c oxidase (COX) deficiency was more severe in patients with PEO than in patients with typical MELAS, even though PEO patients had a lower percentage of mutant genomes in muscle. These data imply that the 3243 mutation is a major cause of familial PEO, and suggests that the threshold number of mtDNAs harboring the 3243 mutation necessary to affect a particular tissue vary in different patients. The proportion of mutant genomes in combination with other, still undefined, tissue-specific modulating factors seem to determine the overall clinical syndrome.

KW - MELAS

KW - mtDNA

KW - PEO

UR - http://www.scopus.com/inward/record.url?scp=0027335882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027335882&partnerID=8YFLogxK

U2 - 10.1016/0960-8966(93)90040-Q

DO - 10.1016/0960-8966(93)90040-Q

M3 - Article

C2 - 8392410

AN - SCOPUS:0027335882

VL - 3

SP - 43

EP - 50

JO - Neuromuscular Disorders

JF - Neuromuscular Disorders

SN - 0960-8966

IS - 1

ER -